4.7 Article

Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Microbiology

Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update

Naveen Kumar Devanga Ragupathi et al.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2019)

Article Chemistry, Multidisciplinary

Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis

Nashrawan Lababidi et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Biochemistry & Molecular Biology

From molecules to multispecies ecosystems: the roles of structure in bacterial biofilms

Vernita Gordon et al.

PHYSICAL BIOLOGY (2019)

Review Critical Care Medicine

Cystic Fibrosis 2017-The Year in Review

Bruce K. Rubin

RESPIRATORY CARE (2018)

Article Biochemistry & Molecular Biology

N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why

Giancarlo Aldini et al.

FREE RADICAL RESEARCH (2018)

Review Infectious Diseases

Role of bacterial efflux pumps in biofilm formation

Ilyas Alav et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Review Nutrition & Dietetics

Vitamin C and Infections

Harri Hemila

NUTRIENTS (2017)

Article Public, Environmental & Occupational Health

Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections

Omar M. El-Halfawy et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2017)

Article Biotechnology & Applied Microbiology

Evolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production

Kristin Kovach et al.

NPJ BIOFILMS AND MICROBIOMES (2017)

Article Microbiology

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms

Sarah Kennedy et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Review Medicine, General & Internal

Cystic fibrosis

J. Stuart Elborn

LANCET (2016)

Article Respiratory System

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection

Anjali Y. Bhagirath et al.

BMC PULMONARY MEDICINE (2016)

Article Cell Biology

Oxidation increases mucin polymer cross-links to stiffen airway mucus gels

Shaopeng Yuan et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Respiratory System

Oxidation contributes to low glutathione in the airways of children with cystic fibrosis

Anthony J. Kettle et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Review Pharmacology & Pharmacy

New Therapies in Cystic Fibrosis

Felix Ratjen et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Article Cardiac & Cardiovascular Systems

Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience

Anthony De Soyza et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)

Review Medicine, General & Internal

Cystic fibrosis

Jane C. Davies et al.

BMJ-BRITISH MEDICAL JOURNAL (2007)

Article Microbiology

Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments

K Chen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Medical Laboratory Technology

Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading?

JE Moore et al.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2005)

Article Multidisciplinary Sciences

Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel

H Fischer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Physiology

The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells

YXQ O'Malley et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)